Suppr超能文献

转移性乳腺癌的手术治疗:具有良好特征的患者似乎从手术中获益最大。

Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery.

机构信息

Department of Surgery, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, Netherlands.

出版信息

Eur J Surg Oncol. 2012 Jan;38(1):52-6. doi: 10.1016/j.ejso.2011.10.004. Epub 2011 Oct 26.

Abstract

INTRODUCTION

About 3-10% of breast cancer patients have distant metastases (Stage IV) at initial presentation; standard treatment (in the Netherlands) of these patients consists of palliative systemic therapy. However, retrospective studies have shown an improved survival in patients who received surgery for their primary tumor. The aim of this study was to assess characteristics associated with surgical treatment and to determine the impact on survival in women with stage IV breast cancer.

METHODS

A cohort of women with a diagnosis of breast cancer and concomitant distant metastases was retrospectively studied. Patient characteristics, treatment and survival distilled from medical files were evaluated using univariate and multivariable analysis.

RESULTS

Of 171 patients included in this analysis, 59 underwent surgery. In multivariable analysis lower age, no medication use, lower clinical T-stage and lower grade were associated with receiving surgery. In 21 of the 59 patients (35%) who received surgery it was unknown at the time of surgery that the patient had metastatic disease. Stratified survival analyses showed an association between surgery and improved survival for young patients (HR 0.3; p = 0.02), without comorbidity (HR 0.4; p = 0.002), with no medication use (HR 0.5; p = 0.009), with a small tumor (HR 0.4; p = 0.01), no regional lymph node involvement (HR 0.4; p = 0.01), with positive Estrogen (HR 0.6; p = 0.02) or Progesterone receptor (HR 0.4; p = 0.03) and with only visceral metastases (HR 0.5; p = 0.03). In multivariable analyses, younger patients and patients without comorbidity that received surgery had an increased survival (HR 0.3; p = 0.03 and HR 0.5; p = 0.03, respectively).

CONCLUSION

This study showed that patients with the most favorable profile receive local surgery and that a survival gain for operated patients was seen in young patients and in patients without comorbidity.

摘要

介绍

约 3-10%的乳腺癌患者在初诊时已有远处转移(IV 期);这些患者的标准治疗(在荷兰)包括姑息性全身治疗。然而,回顾性研究显示,接受原发肿瘤手术治疗的患者生存时间有所改善。本研究旨在评估与手术治疗相关的特征,并确定其对 IV 期乳腺癌患者生存的影响。

方法

本研究回顾性分析了一组诊断为乳腺癌并伴有远处转移的患者。从病历中提取患者特征、治疗方法和生存情况,进行单因素和多因素分析。

结果

在本分析中纳入的 171 名患者中,有 59 名接受了手术。多因素分析显示,年龄较小、未使用药物、临床 T 分期较低和分级较低与接受手术治疗相关。在接受手术的 59 名患者中,有 21 名(35%)在手术时并不知道患者患有转移性疾病。分层生存分析显示,手术与年轻患者(HR 0.3;p=0.02)、无合并症(HR 0.4;p=0.002)、未使用药物(HR 0.5;p=0.009)、肿瘤较小(HR 0.4;p=0.01)、无区域淋巴结受累(HR 0.4;p=0.01)、雌激素受体阳性(HR 0.6;p=0.02)或孕激素受体阳性(HR 0.4;p=0.03)以及仅存在内脏转移的患者(HR 0.5;p=0.03)的生存改善相关。多因素分析显示,接受手术的年轻患者和无合并症患者的生存时间延长(HR 0.3;p=0.03 和 HR 0.5;p=0.03)。

结论

本研究表明,具有最有利特征的患者接受局部手术治疗,接受手术治疗的患者在年轻患者和无合并症患者中生存获益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验